![]() | - SMTL ID
- 5vl3.1
- Ligands
- 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Polypeptides
- B-cell receptor CD22; Epratuzumab Fab Heavy Chain; Epratuzumab Fab Light Chain
- Oligo-state
- hetero-1-1-1-mer
|
![]() | - SMTL ID
- 5vl3.2
- Ligands
- 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Polypeptides
- B-cell receptor CD22; Epratuzumab Fab Heavy Chain; Epratuzumab Fab Light Chain
- Oligo-state
- hetero-1-1-1-mer
|
![]() | - SMTL ID
- 5vl3.3
- Ligands
- 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; GLYCEROL
- Polypeptides
- B-cell receptor CD22; Epratuzumab Fab Heavy Chain; Epratuzumab Fab Light Chain
- Oligo-state
- hetero-1-1-1-mer
|
![]() | - SMTL ID
- 5vl3.4
- Ligands
- 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- Polypeptides
- B-cell receptor CD22; Epratuzumab Fab Heavy Chain; Epratuzumab Fab Light Chain
- Oligo-state
- hetero-1-1-1-mer
|